Ignite Creation Date:
2024-05-06 @ 12:54 PM
Last Modification Date:
2024-10-26 @ 1:05 PM
Study NCT ID:
NCT03876769
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-11
First Post:
2018-11-12
Brief Title:
Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-06-24
Start Date Type:
ACTUAL
Primary Completion Date:
2027-10-19
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-10-19
Completion Date Type:
ESTIMATED
First Submit Date:
2018-11-12
First Submit QC Date:
March 12 2019
Study First Post Date:
2019-03-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-25
Last Update Post Date:
2024-06-11
Last Update Post Date Type:
ACTUAL